What to look forward to in GaBI Journal, 2013, Issue 2

Author(s): Professor Philip D Walson, MD

The first of two Letters to the Editor is from Ms Gaspani and Ms Milani expressing their concerns about the lack of clear regulatory guidelines for approval of liposomal generic formulations. Liposomal products are only one and perhaps some of the best-characterized example of non-biological complex drugs (NBCDs). NBCDs while not having a biological source […]

Read more →